Manuscripts
Showing 1543 manuscripts.
Quantitative Human Immunodeficiency Virus (HIV)-1 Antibodies Correlate With Plasma HIV-1 RNA and Cell-associated DNA Levels in Children on Antiretroviral Therapy.
Citation
A Gautam, R Brody, ER Weiss, D Persaud, E Mick, K Lazuriaga, PACTG 356 Investigators, M McManus, J Henderson. Quantitative Human Immunodeficiency Virus (HIV)-1 Antibodies Correlate With Plasma HIV-1 RNA and Cell-associated DNA Levels in Children on Antiretroviral Therapy.. Clinical Infectious Diseases. 2019. PMID: 30668843Year
2019
Journal
Clinical Infectious Diseases
Tenofovir concentrations in hair strongly predict virologic suppression in breastfeeding women
Citation
Judith S Currier, Sean Brummel, Hideaki Okochi, Nhi Phung, Alexander Louie, Karen Kuncze, Risa M Hoffman, Teacler Nematadzira, Dean K Soko, Maxensia Owor, Friday Saidi, Patricia M Flynn, Mary G Fowler, Monica Gandhi, Pamela M Murnane, Peter Bacchetti. Tenofovir concentrations in hair strongly predict virologic suppression in breastfeeding women. AIDS. 2019. 33: 1657-1662. PMID: 31021852Year
2019
Journal
AIDS
Study
1077BF
Neurodevelopmental effects of ante-partum and post-partum antiretroviral exposure in HIV-exposed and uninfected children versus HIV-unexposed and uninfected children in Uganda and Malawi: a prospective cohort study
Citation
Lillian W Ogwang, Rachel Kawalazira, Alla Sikorskii, Itziar Familiar-Lopez, Agatha Kuteesa, Mary Nyakato, Alex Mutebe, Jackie L Namukooli, MacPherson Mallewa, Horacio Ruiseñor-Escudero, Jim Aizire, Taha E Taha, Mary G Fowler, Michael J Boivin, Limbika Maliwichi-Senganimalunje, MG Fowler. Neurodevelopmental effects of ante-partum and post-partum antiretroviral exposure in HIV-exposed and uninfected children versus HIV-unexposed and uninfected children in Uganda and Malawi: a prospective cohort study. Lancet HIV. 2019. 6: e518-530. PMID: 31122797Year
2019
Journal
Lancet HIV
Study
1077BF
Live-Attenuated Respiratory Syncytial Virus Vaccine With Deletion of RNA Synthesis Regulatory Protein M2-2 and Cold Passage Mutations Is Over-attenuated
Citation
P Muresan, U Buchholz, EJ McFarland, IMPAACT 2012 Study Team, C Perlowski, J Libous, B Thumar, D Gnanashanmugam, J Moye Jr, E Schappell, E Barr, V Rexroad, M Aziz, J Deville, R Rutstein, L Yang, CK Cunningham, C Luongo, R Karron, P Collins. Live-Attenuated Respiratory Syncytial Virus Vaccine With Deletion of RNA Synthesis Regulatory Protein M2-2 and Cold Passage Mutations Is Over-attenuated. Open Forum Infectious Diseases. 2019. 6: 212. PMID: 31211158Year
2019
Journal
Open Forum Infectious Diseases
Study
IMPAACT 2012
Slow Acceptance of Universal Antiretroviral Therapy (ART) Among Mothers Enrolled in IMPAACT PROMISE Studies Across the Globe
Citation
P Flynn, PROMISE study team, J Pilotto, M Mubiana-Mbewe, M Mutambanengwe, R Oliveira, V Chanaiwa, T Anekthananon, T Mhembere, P Mlay, M Kamateeka, K Angelidou, J Aizire, C Tierney, G Masheto, L Ziemba, R Chamanga, A Coletti, M Maluwa, K McCarthy, S Hanley, M Basar, E Joao, N Chakhtoura, G Theron, R Browning, N Nevrekar, J Currier, M Nyati, MG Fowler, L Stranix-Chibanda, B Santos, S Brummel, L Aurpibul. Slow Acceptance of Universal Antiretroviral Therapy (ART) Among Mothers Enrolled in IMPAACT PROMISE Studies Across the Globe. AIDS and Behavior. 2019. 23: 2522-2531. PMID: 31399793Year
2019
Journal
AIDS and Behavior
Study
1077HS, 1077BF, 1077FF
Maternal Humoral Immune Responses Do Not Predict Postnatal HIV-1 Transmission Risk in Antiretroviral-Treated Mothers from the IMPAACT PROMISE Study
Citation
Joshua A Eudailey, Kevin Butler, Whitney Edwards, Justin Pollara, Sean S Brummel, Genevieve G Fouda, Lemeck Chinula, Melvin Kamanga, Aarti Kinikar, Dhayendre Moodley, Maxensia Owor, Mary Glenn Fowler, Sallie R Permar, Eliza D Hompe, Denise L Jacobson. Maternal Humoral Immune Responses Do Not Predict Postnatal HIV-1 Transmission Risk in Antiretroviral-Treated Mothers from the IMPAACT PROMISE Study. mSphere. 2019. 4: e00716-19. PMID: 31645430Year
2019
Journal
mSphere
Study
1077BF, 1077FF
Establishing Dosing Recommendations for Efavirenz in HIV/TB-Coinfected Children Younger than 3 Years.
Citation
EV Capparelli, CB Moore, P Jean-Philippe, SA Spector, N Chakhtoura, A Benns, B Zimmer, L Purdue, C Jackson, C Wallis, JL Libous, EG Chadwick, IMPAACT P1070 Study Team, M Bwakura Dangarembizi, P Samson. Establishing Dosing Recommendations for Efavirenz in HIV/TB-Coinfected Children Younger than 3 Years.. Journal of Acquired Immune Deficiency Syndromes. 2019. 81: 473-480. PMID: 31241542Year
2019
Journal
Journal of Acquired Immune Deficiency Syndromes
Study
P1070
Extended Prophylaxis With Nevirapine Does Not Affect Growth in HIV-Exposed Infants.
Citation
RS Mwiru, A Mwatha, AM Young, D Moodley, HM Coovadia, L Staranix-Chibanda, K Manji, Y Maldonado, P Richardson, P Andrew, K George, W Fawzi, MG Fowler, C Onyango-Makumbi, AH Owora. Extended Prophylaxis With Nevirapine Does Not Affect Growth in HIV-Exposed Infants.. Journal of Acquired Immune Deficiency Syndromes. 2019. 82: 377-385. PMID: 31567725Year
2019
Journal
Journal of Acquired Immune Deficiency Syndromes
Use of Modeling and Simulations to Determine Raltegravir Dosing in Neonates: A Model for Safely and Efficiently Determining Appropriate Neonatal Dosing Regimens: IMPAACT P1110
Citation
Edward P Acosta, Edmund Capparelli, Anne Chain, Hedy Teppler, Betsy Smith, Jos Lommerse, International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) P1110 Study Team, Diana F Clarke, Mark Mirochnick. Use of Modeling and Simulations to Determine Raltegravir Dosing in Neonates: A Model for Safely and Efficiently Determining Appropriate Neonatal Dosing Regimens: IMPAACT P1110. Journal of Acquired Immune Deficiency Syndromes. 2019. 82: 392-398. PMID: 31658182Year
2019
Journal
Journal of Acquired Immune Deficiency Syndromes
Study
P1110